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bioprosthetic valve implantation in the mitral position.1 Radiofre-
quency maze lesion lines were unlikely to be a source leading to
propagation onto the valve leaflets because there were no intra-
atrial clots and thrombus was laminar along all the valve leaflets.
Intravenous heparin was started in this patient with a plan to
commence thrombolytic therapy if heparin alone was ineffective.
Although thrombolytic therapy is an established first-line treat-
ment, this patient responded to heparin anticoagulation followed
by warfarin. Several studies have reported good resolution of
bioprosthetic thrombus after conventional anticoagulation.2-5 Con-
curring with these studies, we had a favorable result after 1 week
of heparin and subsequent warfarinization.
Clinically significant bioprosthetic valve thrombosis is rare,
although the reported incidence in the study by Oliver and col-
leagues5 is 6.2%. It should be considered a possible cause of valve
dysfunction when there is increasing transvalvular pressure gradi-
ent after anticoagulation is terminated. Treatment with conven-
tional anticoagulation is unavoidable in such a setting.
References
1. Stein PD, Alpert JS, Dalen JE, Horstkotte D, Turpie AG. Antithrom-
botic therapy in patients with mechanical and biological prosthetic heart
valves. Chest. 1998;114(suppl 5):602S-10S.
2. Thomas B, Carreras F, Borras X, Pons-Lladó G. An usual case of
bioprosthetic mitral valve thrombosis. Ann Thorac Surg. 2001;72:
259-61.
3. Korkolis DP, Passik CS, Marshalko SJ, Koullias GJ. Early bioprosthetic
mitral valve “pseudostenosis” after complete preservation of the native
mitral apparatus. Ann Thorac Surg. 2002;74:1689-91.
4. Koppensteiner R, Moritz A, Schlick W, et al. Blood rheology after
cardiac valve replacement with mechanical prostheses or bioprostheses.
Am J Cardiol. 1991;67:79-83.
5. Oliver JM, Galloge P, Gonzalez A, Dominguez FJ, Gamallo C, Mesa
JM. Bioprosthetic mitral valve thrombosis: clinical profile, transesoph-
ageal echocardiographic features, and follow-up after anticoagulant
therapy. J Am Soc Echocardiogr. 1996;9:691-9.
A case of mitral valve plasty for Libman–Sacks
endocarditis mimicking a cardiac tumor
Shingo Taguchi, MD, Kazuhiro Hashimoto, MD, Yoshimasa Sakamoto, MD,
Hiroshi Okuyama, MD, and Shinichi Ishii, MD, Tokyo, Japan
We report a patient with multiple cerebral infarcts inwhom 2-dimensional echocardiography showed alarge mass attached to the anterior mitral leafletand chordae. An intracardiac tumor was diag-
nosed, and surgical intervention was performed. The resected mass




found in patients with systemic lupus erythematosus (SLE).
Unique echocardiographic and intracardiac findings are reported
here with the technique of mitral valve plasty.
Clinical Summary
A 34-year-old woman was admitted after the sudden onset of
aphasia associated with mild hemiplegia of her left arm and leg.
She had been receiving treatment for SLE for 9 years, but the
disease had been inactive, and she had been well, except for
numbness in her left hand, at 7 months before this episode. Her
medications were an H2 blocker and an oral steroid (5 mg/d
prednisolone). Admission laboratory tests revealed normal serum
chemistry, normal C-reactive protein (CRP) levels, no anemia, and
mild thrombocytopenia (the platelet count was 55  103/L).
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Figure 2. Doppler scan showing increased mean mitral pressure
gradient (mean mitral pressure gradient 24 mm Hg).
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Antinuclear antibody was positive (titer 1:80), but other autoanti-
bodies were normal. Magnetic resonance imaging revealed multi-
ple focal infarcts in the left cerebral hemisphere, pons, and P4 area
corresponding to the territory of the right posterior communicating
artery. Two-dimensional transthoracic echocardiography revealed
a mobile mass like bunches of grapes (1.5 cm in diameter) attached
to the A3 area of the anterior mitral leaflet and the chordae of the
mitral valve adjacent to the anterior papillary muscle (Figure 1, A).
The mitral valve demonstrated normal movement, with no evi-
dence of stenosis or chordal rupture, although trivial regurgitation
was detected at the center of the orifice. On the basis of the size
and mobility of the tumor, its potential for further systemic em-
bolization was considered to be high, and the patient underwent
surgical intervention. At the time of the operation, all intracardiac
manipulations were performed through an aortotomy. The mass
was first observed by means of endoscopy (Figure 2) and was
found to be multifocal in origin, arising from the anterior mitral
leaflet, the chordal apparatus, and the septum of the left ventricular
outflow tract. The mass was excised as completely as possible, and
a few chordae were also removed with it. Intraoperative pathology
revealed the typical appearance of a Libman–Sacks vegetation, and
it was distinguished from other lesions such as bacterial vegeta-
tions, myxoma, or papillary fibroelastoma. The surface of the
anterior mitral leaflet that had been attached to the mass was
rubbed thoroughly with a sponge, and the involved chordae were
resected further. Then the anterior leaflet was supported with 4
artificial polytetrafluoroethylene chordae,* which were placed with
the loop technique.1 The patient’s postoperative course was good
(Figure 1, B), and she was discharged 14 days after the operation.
The antinuclear antibody titer has been well controlled by means
of steroid therapy, and CRP levels remain negative.
Discussion
Intracardiac masses attached to the mitral valve and chordae are
most frequently seen in infective endocarditis. When other features
of infective endocarditis, such as fever, an increased white blood
cell count, or increase of CRP levels, are not observed at present
or in the past, a clinical diagnosis of cardiac tumor is usually made.
Tumors arising from valvular tissue are usually considered to be
myxomas or papillary fibroelastomas because of their frequency
and site of origin. In 20 years’ experience of papillary fibroelas-
tomas at the Mayo Clinic, there were 10 lesions arising from the
anterior mitral leaflet, papillary muscles, or both in a series of 88
cases.2 In patients with SLE, however, Libman–Sacks endocarditis
might be strongly suspected, although the frequency of detection
by means of echocardiography is lower than the frequency ob-
served at autopsy. Galve and colleagues3 reported 7 cases of
vegetations detected by means of echocardiography and compati-
ble with Libman–Sacks endocarditis in a series of 74 patients.
Libman–Sacks endocarditis occurs on the aortic and mitral valves
or submitral apparatus in most cases, and the affected chordae some-
times undergo rupture.4,5 Valve replacement has been the technique
of first choice because resection of the mass and valve tissue en bloc
will definitely prevent recurrence. In fact, all reports of surgical
intervention for Libman–Sacks endocarditis involved valve replace-
ment, as far as we could determine by review.5 Libman–Sacks endo-
carditis is not a neoplasm but represents degeneration caused by
*Gore-Tex chordae, registered trademark of W. L. Gore & Associates, Inc,
Newark, Del.
Figure 1. Parasternal long-axis view of echocardiography. A,
Vegetation attached to the anterior mitral leaflet and chorda. B,
The mitral valve is competent without mitral regurgitation after
the operation. Ao, Aorta; LA, left atrium; LV, left ventricle.
Figure 2. Mass observed with a telescope through the aortotomy.
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fibrinoid or inflammatory changes, and therefore appropriate steroid
therapy to control SLE is quite important to prevent its recurrence. In
other words, mitral valve plasty (particularly in patients without mitral
regurgitation) is thought to be an appropriate option if good control of
SLE is possible. At 6 months after the operation, our patient showed
no evidence of recurrence on echocardiography.
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Giant cell aortitis with histopathologic and clinical response to steroid
therapy: A case report
Howard Blumstein, MD,a Leslie Dubin Kerr, MD,a and John T. Fallon, MD, PhD,b New York, NY
Giant cell arteritis (GCA) is a large-vessel vasculitisthat affects older individuals and typically presentswith constitutional symptoms, polymyalgia, head-ache, scalp tenderness, jaw claudication, or sudden
vision loss.1
A subset of patients with GCA can present with large artery
disease consisting of aortic aneurysm, dissection, or both.2 We
have also recently described our own experience with 19 such
patients who underwent surgical repair of aortic aneurysms and
who were found to have unsuspected giant cell aortitis on his-
topathologic review.3 This study suggested that large-vessel giant
cell aortitis might be a different disease from classic GCA because
of its unusual clinical presentation. No conclusions, however,
could be drawn regarding the effectiveness of subsequent steroid
therapy for this variant of the disease.
A unique opportunity to explore this question arose when a
patient with 2 known aortic aneurysms presented. Giant cell aor-
titis was documented at the repair of the first aneurysm. This patient
subsequently lost vision and hearing and regained both after steroid
therapy. When the second repair was performed 14 months later,
the histopathologic effect of steroid treatment was assessed.
Clinical Summary
A 67-year-old woman in whom 2 large aneurysms, a thoracic and
a thoracoabdominal aneurysm, had been incidentally found on
computed tomographic scanning was referred for cardiac catheter-
ization and further management. The catheterization demonstrated
severe left main disease, normal left ventricular function, a dilated
aortic root with severe aortic insufficiency, and mild narrowing of
the right subclavian artery. The patient then underwent a stage I
Bentall procedure with osteoplasty of the left main coronary artery.
The repair of the thoracoabdominal aneurysm was deferred. On
postoperative day 2, she experienced sudden loss of vision in her
left eye. The pathology report documented the presence of active
giant cell aortitis, and rheumatology consultation was requested.
On initial evaluation, the patient denied antecedent symptoms of
polymyalgia, headache, scalp tenderness, jaw claudication, joint
pains, or constitutional symptoms. She described her vision loss as
sudden and accompanied by decreased hearing.
On physical examination, she had no scalp or temporal
artery tenderness, and no bruits were appreciated. There was no
evidence of synovitis or muscle tenderness. Visual acuity was
markedly reduced, and hearing was diminished. Her sedimen-
tation rate was 31 mm/h (Westergren). Treatment with high-
dose intravenous steroids (dexamethasone, 4.5 mg every 12
hours) was begun. Over the next 2 weeks, her vision improved
only marginally, and the steroids were then tapered to 5 mg/d.
This dose was continued, and at 1 month postoperatively, the
patient suddenly regained vision in her left eye and noted
restoration of hearing. Prednisone, 5 mg/d, was continued for 6
months and then discontinued. Fourteen months after the initial
repair, the patient then underwent repair of the remaining
thoracoabdominal aneurysm. This specimen demonstrated se-
vere atherosclerotic changes with mural thrombus; no evidence
of discrete aortitis was seen. The patient had an uneventful
hospital course and was discharged without steroid therapy.
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